Day 1 – Tuesday, 6th december 2022
CET Time, Lithuania +1h
Welcome speeches / Introduction
- Dr André Le Bivic, Director of the CNRS Institute of Biological Sciences (INSB)
- Mrs Jurgita Šiugždinienė, Minister of Education, Science and Sport of Lithuania
- Mr Nerijus Aleksiejūnas, Ambassador of Lithuania in France
- Dr Etienne Snoeck, Deputy Director for Europe, European Research and International Cooperation Department, CNRS
Topic 1: Cancer
Morning Chairperson: Dr. Aušra SASNAUSKIENĖ, Vilnius University Life Sciences Center
9:30 – 10:00
CET Time, Lithuania +1h
Prof. Dr. Juozas KUPČINSKAS, Lithuanian University of Health Sciences (LSMU)-Kaunas Clinics
Microbiome and molecular alterations in gastrointestinal inflammation and cancer
10:00 – 10:30
CET Time, Lithuania +1h
Dr. Judith MINE-HATTAB, The Laboratory of Computational and Quantitative Biology (LCQB)
Single-molecule microscopy during early chromatin remodeling upon DNA damag
10:30 – 11:00
CET Time, Lithuania +1h
Dr. Jan Aleksander KRASKO and Dr. Olha KARAMAN, National Cancer Institute
Cytokine-induced killer cells and bacterial lectins: new opportunities for cancer therapy (the presentation will be given by Dr. Jan Aleksander KRASKO)
11:00 – 11:15
CET Time, Lithuania +1h
Coffee break (15min)
11:15 – 11:45
CET Time, Lithuania +1h
Dr. Jérémie ROUX, Institute of Molecular and Cellular Pharmacology
Coupling dynamic imaging and in situ isolation of the same single-cell, to profile the non-genetic determinants of predicted drug-tolerant cells with fate-seq
11:45 – 12:15
CET Time, Lithuania +1h
Dr. Mindaugas VALIUS, Vilnius University Life Sciences Center
Proteomics for the elucidation of anticancer drug resistance and drug repurposing
12:15 – 13:30
CET Time, Lithuania +1h
Lunch break (1h15)
Afternoon Chairperson: Laura PĖKIĖNĖ, NCP Horizon Europe (Health, Cancer mission); Research Council of Lithuania
13:30 – 14:00
CET Time, Lithuania +1h
Dr. Linas MAŽUTIS, Vilnius University Life Sciences Center
Tackling tumor and immune system heterogeneity using scRNA-Seq
14:00 – 14:30
CET Time, Lithuania +1h
Aurélie TCHOGHANDJIAN, Institute of Neurophysiopathology
Smac mimetic as pan-cellular therapy in glioblastoma
14:30 – 15:00
CET Time, Lithuania +1h
Dr. Andrius ŽUČENKA, Vilnius University Hospital Santaros Klinikos
Biomarker based research of new treatment approaches to relapsed and refractory acute myeloid leukemia
15:00 – 15:30
CET Time, Lithuania +1h
Dr. Eddy PASQUIER
Reverse molecular pharmacology: using existing drugs to discover novel vulnerabilities in refractory cancer
Day 2 – Wednesday, 7th december 2022
Topic 2: Neurodegenerative diseases
Morning Chairperson: Dr. Emmanuel BROUILLET, Research Director at CNRS, Paris
9:00 – 9h30
CET Time, Lithuania +1h
Prof. Dr. Vilmantė BORUTAITĖ, Lithuanian University of Health Sciences (LSMU)-Kaunas Clinics
Neurotoxic effects of extracellular tau and other amyloidogenic proteins
9:>30 – 10:00
CET Time, Lithuania +1h
Dr. Marc DHENAIN, Laboratory of neurodegenerative diseases at the Molecular Imaging Center (MIRCen)
Iatrogenic transmission of β-amyloid and tau proteins: Importance for clinical and biomedical research on Alzheimer’s disease
10:00 – 10:30
CET Time, Lithuania +1h
Dr. Augustas PIVORIŪNAS, Centre for Innovative Medicine
Extracellular vesicles as a potent therapeutic tool against Parkinson’s disease
10:30 – 10:45
CET Time, Lithuania +1h
Coffee break (15min)
10h45 – 11:15
CET Time, Lithuania +1h
Dr. Marie-Claude POTIER
Neuropathological differences between Down syndrome and familial Alzheimer’s disease with APP duplication: role of endothelial cells in cerebral amyloid angiopathy
11:15 – 11:45
CET Time, Lithuania +1h
Dr. Rima BUDVYTYTĖ, Vilnius University Life Sciences Center
The interaction of amyloid ß oligomers with lipid membranes: implications for neurodegeneration
11:55 – 12:15
CET Time, Lithuania +1h
Dr. Hélène MARIE, Institute of Molecular and Cellular Pharmacology (IPMC)
Amyloid precursor protein peptides: physiological modulators of neuronal signaling
12:15 – 13:30
CET Time, Lithuania +1h
Lunch break (1h15)
Topic 3: Infectious Diseases
Afternoon Chairperson: Dr Sylvie GUERDER, Research Director at CNRS, Toulouse
13:30 – 14:00
CET Time, Lithuania +1h
Dr. François TROTTEIN, Center of Infection and Immunity of Lille
Impact of respiratory viral infections on gut microbiota’s composition and functionality : from short chain fatty acids to glycolipids
14:00 – 14:30
CET Time, Lithuania +1h
Prof. Dr. Auksė MICKIENĖ and Vytautas GRIŠKA, Lithuanian University of Health Sciences & Department of Infectious diseases of Lithuanian University of Health Sciences Kaunas Hospital
A prospective study on the long-term outcome and pathogenesis of tick-borne encephalitis/Lithuanian University of Health Sciences (LUHS) and LUHS Kaunas Hospital, Department of Infectious Diseases
14:30 – 15:00
CET Time, Lithuania +1h
Dr. Nicolas PERSONNIC, Centre international de recherche en infectiologie (CIRI)
Single-cell dynamics and persistence of Legionella pneumophila
15:00 – 15:15
CET Time, Lithuania +1h
Coffee break (15min)
15:15 – 15:45
CET Time, Lithuania +1h
Dr. Gytis DUDAS, Vilnius University Life Sciences Center
Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions
15:45 – 17:00
CET Time, Lithuania +1h
Roundtable: Discussion on how to reinforce the collaboration (institutions representatives) and concluding remarks
- Emmanuel BROUILLET, Head, Europe and International Affairs, INSB, CNRS
- Etienne SNOECK, Director for European Affairs, CNRS
Lithuanian representatives:
- Kornelija BACVINKIENĖ, Programme Coordinator for the Lithuanian–French bilateral cooperation Programme; Research Council of Lithuania
- Aurelija POVILAIKĖ, NCP Horizon Europe (ERC and Widening); NCP Coordinator Research Council of Lithuania
- Sigita AUVERTIN, NCP Horizon Europe (Health); Research Council of Lithuania
- Laura PĖKIENĖ, NCP Horizon Europe (Health, Cancer mission); Research Council of Lithuania
- Tadas TUMĖNAS, Head of Lithuanian Research Development and Innovation Liaison Office in Brussels